May 2022 FDA Recall Drug by Remedyrepack Inc.
D-0885-2022 - CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

This Class II drug recall was voluntarily initiated by Remedyrepack Inc. on May 4, 2022 for the product Drug. The FDA reported the reason for recall as cgmp deviations- azido impurity levels observed to be above acceptable limits. The product was distributed in Recalled product was distributed to Florida. and the recall is currently terminated.

Recall Number: D-0885-2022

Reason for Recall
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Initiated
05-04-2022
Reported
06-01-2022
Quantity
22 bottles/90 count each

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Recalled product was distributed to Florida.
Losartan HCTZ 50/12.5 mg, 90 count bottle Original NDC# 33342-0050-10 Repackaged NDC# 70518-3231-00

Batch or Lot Expiration Information

Lot# B1377711-100521, exp. date 10/31/2022 B1412137-102621, exp. date 10/31/2022